| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/06/2008 | US20080057113 virion vaccine anti-herpes simplex viruses containing hi-tech immunomodulator Polyoxidonium ( copolymer of 1,4-ethylene-piperazine N-oxide and (N-carboxyethyl)-1,4-ethylene-piperasinium bromide), valine, lysine together with metabolic amino acids; immunocompetent |
| 03/06/2008 | US20080057112 preparing a high proportion by % wt. of vitamin emulsion; a emulsion of taste masking flavor of strawberry, blue raspberry, bubble gum, orange or lemon; preparing a polymer base of hydroxypropylmethyl cellulose or carboxymethyl cellulose, mixing, and casting to form a film; non bitter taste |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057107 Intravaginally administering mannose phosphate or salt and a carrier to increase viginal cell growth or cell maturation |
| 03/06/2008 | US20080057101 drug elution rate controlling matrix is disposed within the pores such that substantially none of the matrix protrudes from the pores and the porous body protects the matrix material of biocompatible, biodegradable natural or synthetic polymer; stents, endoprosptheses, catheters, dental implants |
| 03/06/2008 | US20080057087 Coating polymer solution onto inert substrate by knife or roller application or spraying and drying, using partially hydrolyzed polyvinyl alcohol, soluble in water; then coating second composition based on polyvinylpyrrolidone, soluble in water, for second layer; quick dissolving; drug delivery |
| 03/06/2008 | US20080057086 Colon-targeted oral formulations of cytidine analogs |
| 03/06/2008 | US20080057083 Protecting an animal against a pathogen by administering protective agent which is able to stimulate the animal's immune system to produce a response which is protective against the pathogen, and an immunostimulant comprising a polycationic carbohydrate or derivative thereof; non-parenteral immunization |
| 03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 03/06/2008 | US20080057073 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 03/06/2008 | US20080057030 comprising administering an effective amount of Interferon-gamma (IFN-gamma) and corticosteroids; treatment of respiratory system disorders |
| 03/06/2008 | US20080057026 Amphiphilic Star-Like Or Scorpion-Like Macromolecules, Various Compositions And Uses Threof |
| 03/06/2008 | US20080057004 Albumin-insulin fusion proteins |
| 03/06/2008 | US20080057003 Powder inhaler formulations |
| 03/06/2008 | US20080057002 Non-aqueous compositions containing urea and allantoin and methods for preparing same |
| 03/06/2008 | US20080056996 Photodynamic therapy for the treatment of hair loss |
| 03/06/2008 | US20080054220 preparing microparticles using in-line solvent extraction. An emulsion is formed by combining two phases in a static mixer. The emulsion is combined with an extraction liquid in a blending mixers |
| 03/06/2008 | US20080053912 Unipolar magnetic medicine carrier |
| 03/06/2008 | US20080053904 Emulsion is formed by combining two phases in static mixer, emulsion is combined with extraction liquid in blending static mixer, outflow of mixer is combined with additional extraction liquid; in-line solvent extraction; encapsulating biologically or pharmaceutically active materials |
| 03/06/2008 | DE112006000873T5 Zusammensetzungen mit modifizierter Freisetzung, umfassend ein Fluorcytidin-Derivate zur Behandlung von Krebs Modified release compositions comprising a fluorocytidine derivatives for the treatment of cancer |
| 03/06/2008 | DE10333384B4 Mischanordnung zum Herstellen flüssiger oder halbfester Produkte Mixing arrangement for producing liquid or semi-solid products |
| 03/06/2008 | DE10136781B4 Flache orale Darreichungsformen mit wirkstoffhaltigen Partikeln Flat oral dosage forms with drug-containing particles |
| 03/06/2008 | CA2670425A1 Pharmaceutical compositions including vitamin d and corticosteroid |
| 03/06/2008 | CA2667330A1 Lipid metabolism improving agent containing hydrogen molecules |
| 03/06/2008 | CA2662315A1 Solid composites of a calcium receptor-active compound |
| 03/06/2008 | CA2662298A1 Topical composition comprising a dihydropyridine calcium antagonist |
| 03/06/2008 | CA2662265A1 Imatinib compositions |
| 03/06/2008 | CA2662219A1 Lyophilized preparation of 1-methylcarbapenem compound |
| 03/06/2008 | CA2662208A1 Food protein and charged emulsifier interaction |
| 03/06/2008 | CA2662122A1 Controlled release solid oral dosage formulations comprising nisoldipine |
| 03/06/2008 | CA2662114A1 Agent for treating eye diseases |
| 03/06/2008 | CA2661912A1 Drug electrotransport with hydration measurement of hydratable reservoir |
| 03/06/2008 | CA2661764A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 03/06/2008 | CA2661754A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 03/06/2008 | CA2661683A1 Drug delivery systems comprising solid solutions of weakly basic drugs |
| 03/06/2008 | CA2661567A1 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same |
| 03/06/2008 | CA2661078A1 Lyophilized preparation |
| 03/06/2008 | CA2660804A1 Reverse targeting lipid vesicle |
| 03/06/2008 | CA2646091A1 Compositions for visualization of vitreous body and methods of using same |
| 03/06/2008 | CA2645037A1 Pharmaceuticals containing fluoroquinolones |
| 03/05/2008 | EP1894565A1 Stabilized milnacipran formulation |
| 03/05/2008 | EP1894563A1 Plaster containing fentanylum |
| 03/05/2008 | EP1894562A1 Pharmaceutical compositions |
| 03/05/2008 | EP1894561A1 Dipyridamole pharmaceutical compositions |
| 03/05/2008 | EP1894560A1 Oral antimicrobial pharmaceutical compositions comprising metronidazole |
| 03/05/2008 | EP1894559A1 Means to solubilise steroids for inhalation |
| 03/05/2008 | EP1894558A1 Agent for external application to the skin |
| 03/05/2008 | EP1894557A1 Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore |
| 03/05/2008 | EP1894477A1 Food protein and charged emulsifier interaction |
| 03/05/2008 | EP1893396A2 Foamable vehicle and pharmaceutical compositions thereof |
| 03/05/2008 | EP1893326A2 Methods and systems for coating particles |
| 03/05/2008 | EP1893277A1 A plaster device |
| 03/05/2008 | EP1893237A1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle |
| 03/05/2008 | EP1893236A2 Direct compression formulation of dpp-iv inhibitors and glitazones, and process |
| 03/05/2008 | EP1893231A2 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 03/05/2008 | EP1893217A2 Tanaproget compositions containing ethinyl estradiol |
| 03/05/2008 | EP1893216A1 Methods and compositions for the treatment of ocular disorders |
| 03/05/2008 | EP1893204A2 Formulations comprising fluphenazine or derivatives thereof |
| 03/05/2008 | EP1893184A2 Oral dosage form comprising an antimisuse system |
| 03/05/2008 | EP1893183A1 Emetic embedded capsule |
| 03/05/2008 | EP1893182A2 Oral dosage forms comprising progesterone and methods of making and using the same |
| 03/05/2008 | EP1893181A1 Oral dosage form comprising at least one active principle having a solubility that varies as a function of gastric ph conditions |
| 03/05/2008 | EP1893180A2 Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
| 03/05/2008 | EP1893179A2 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| 03/05/2008 | EP1893178A1 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS |
| 03/05/2008 | EP1893177A1 Water soluble analgesic formulations and methods for production |
| 03/05/2008 | EP1893176A1 Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying |
| 03/05/2008 | EP1893175A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 03/05/2008 | EP1893174A2 Injectable hydrogels and methods of making and using same |
| 03/05/2008 | EP1893157A1 Attachment of a handle to a solid oral dosage form |
| 03/05/2008 | EP1893144A1 Medical devices and methods for producing the same |
| 03/05/2008 | EP1802259B1 Self-sealing antiseptic plaster |
| 03/05/2008 | EP1575656A4 Insulin delivery system with sensor |
| 03/05/2008 | EP1545231B1 Sweet containing calcium |
| 03/05/2008 | EP1409474B1 Method for the production of dronabinol |
| 03/05/2008 | EP1368253B1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 03/05/2008 | EP1233969B1 Mono- and disaccharide derivatives |
| 03/05/2008 | EP1059942B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 03/05/2008 | EP0690912B1 Recombinant avian adenovirus vector |
| 03/05/2008 | CN201030063Y Antiperspirant plaster |
| 03/05/2008 | CN201029977Y Thermoregulation pad with ventilating function |
| 03/05/2008 | CN201029954Y Medicine-releasing electric capsule |
| 03/05/2008 | CN201029953Y Sustained-release electric capsule |
| 03/05/2008 | CN101137700A Microparticle and pharmaceutical composition |
| 03/05/2008 | CN101137395A Pharmaceutical composition containing hardly water soluble medicament |
| 03/05/2008 | CN101137383A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution |
| 03/05/2008 | CN101137365A Pharmaceutical compositions comprising sirolimus and/or an analogue thereof |
| 03/05/2008 | CN101137364A Compositions comprising an epothilone and production methods |
| 03/05/2008 | CN101137356A Adhesive and plaster |
| 03/05/2008 | CN101137355A Non-fibrous transdermal therapeutic system and method for its production |
| 03/05/2008 | CN101137354A Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating |
| 03/05/2008 | CN101137353A Compositions comprising entrained water and agents entrained in water-sensitive matrices |
| 03/05/2008 | CN101137352A Pharmaceutical formulations and methods of use |
| 03/05/2008 | CN101137351A Alfuzosin controlled-release formulations |
| 03/05/2008 | CN101137350A Gastroresistant pharmaceutical formulations containing rifaximin |
| 03/05/2008 | CN101137349A Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 03/05/2008 | CN101137348A Microemulsions of cannabinoid receptor binding compounds |
| 03/05/2008 | CN101137347A Active substance delivery system comprising a hydrogel atrix and microcarriers |
| 03/05/2008 | CN101137333A Formulations for coated microprojections having controlled solubility |